NCBI found that with fewer side effects, delta-8 THC may offer many experiential advantages of delta-9 THC. Even though these investigations are hampered by the lawful statuses of both delta-8 THC and delta-9 THC, a future systematic study is required to verify participant accounts. Collaborations between the academic, governmental, and cannabis industry sectors may hasten the development of knowledge about Delta-8 THC and other cannabinoids.